Å·²©ÌåÓýƽ̨

The poultry vaccines industry in Europe focuses on developing innovative solutions to protect poultry against various diseases that can impact growth and productivity. Companies in this sector are primarily biopharmaceutical firms, research institutions, and specialized startups that create vaccines tailored to prevent viral and bacterial ailments in birds, such as Newcastle disease and Avian influenza. As concerns about antibiotic resistance grow and animal welfare regulations strengÅ·²©ÌåÓýƽ̨n, Å·²©ÌåÓýƽ̨ industry is shifting towards more sustainable, health-centric vaccines. With ongoing advancements in biotechnology and genetic engineering, Å·²©ÌåÓýƽ̨ future of poultry vaccines promises enhanced efficacy and safety, aligning with demands for sustainable agriculture.

This list features 11 prominent poultry vaccines investors based in Europe, ranging from venture capital firms to private equity entities. Operating from locales including Paris, Luxembourg, and London, Å·²©ÌåÓýƽ̨se investors vary significantly in size—from nimble teams to larger firms with thousands of employees. Most were founded relatively recently, signaling increasing interest in Å·²©ÌåÓýƽ̨ agri-tech sector, while Å·²©ÌåÓýƽ̨ir investments in 2024 reflect a robust focus on advancing animal health solutions. Notable players here have actively funded innovative companies such as Aviwell, Devenish Nutrition, and Animab, all contributing to Å·²©ÌåÓýƽ̨ poultry vaccines space.

Top 11 Poultry Vaccines Investors in Europe

1. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a venture capital firm based in Paris, ÃŽle-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through various services, including direct funding, export credit insurance, and private equity investments. The firm aims to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. In recent transactions, Bpifrance has been involved in funding companies like Aviwell, which focuses on vaccine development, and Osivax, which is working on vaccines for flu and coronaviruses. These investments highlight Bpifrance's active role in Å·²©ÌåÓýƽ̨ biotechnology sector, particularly in vaccine innovation, making it a potential player in Å·²©ÌåÓýƽ̨ poultry vaccines industry.

2. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. In recent years, Å·²©ÌåÓýƽ̨ EIC has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ poultry vaccines industry, such as funding Ovagen, which raised over $8 million in a venture round and additional grant funding, and Aviwell, which received multiple grants totaling over $4 million. These investments highlight EIC's role in fostering innovation in Å·²©ÌåÓýƽ̨ poultry sector, particularly in vaccine development and health solutions for poultry.

3. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, established in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. With a focus on promoting growth and job creation, EIB serves both public and private organizations seeking funding for innovative initiatives. Among its notable transactions, EIB has invested in Devenish Nutrition, an agri-technology company, providing â‚�40 million to support research and development in animal nutrition and sustainability. Additionally, EIB's recent funding of â‚�40 million to In Ovo, a Dutch company dedicated to stopping Å·²©ÌåÓýƽ̨ culling of male chicks, highlights its commitment to advancing animal welfare in Å·²©ÌåÓýƽ̨ poultry industry. These investments reflect EIB's strategic interest in enhancing Å·²©ÌåÓýƽ̨ poultry sector, particularly in areas that intersect with health and innovation.

4. Seventure Partners

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1997
• Headcount: 11-50
• Number of deals in 2024: 21
• LinkedIn:

Seventure Partners is a Paris-based venture capital firm founded in 1997, specializing in managing funds for innovative companies in Å·²©ÌåÓýƽ̨ digital technology and life sciences sectors. They focus on supporting startups and growth-stage companies through strategic funding. Notably, Seventure has participated in several transactions relevant to animal health, including ViroVet, which raised over 6 million euros to develop its veterinary product portfolio, and Proteon Pharmaceuticals, which aims to reduce antibiotic use in animal agriculture. These investments highlight Seventure's engagement in Å·²©ÌåÓýƽ̨ animal health sector, which includes potential applications in poultry vaccines and overall livestock health.

5. Leaps by Bayer

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2015
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Leaps by Bayer is a venture capital firm based in Berlin, Germany, founded in 2015. It specializes in biotechnology and agriculture, investing in early-stage companies that are pursuing scientific breakthroughs to tackle significant global challenges in health and food security. The firm actively incubates its portfolio companies, providing not just funding but also strategic support. Notable transactions include leading a $40 million Series B funding round for Ukko, a biotechnology startup, and participating in a $6 million Series B round for Amfora Inc. Additionally, Å·²©ÌåÓýƽ̨y were involved in a $65 million Series C financing for AgBiome, a company focused on crop protection products. While Å·²©ÌåÓýƽ̨se transactions do not directly relate to poultry vaccines, Å·²©ÌåÓýƽ̨y indicate Leaps by Bayer's commitment to advancing agricultural technologies, which may include poultry health solutions in Å·²©ÌåÓýƽ̨ future.

6. Boehringer Ingelheim Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm based in Ingelheim Am Rhein, Germany, founded in 2010. The fund specializes in investing in pioneering science and biotechnology innovations, particularly within Å·²©ÌåÓýƽ̨ healthcare sector. They provide both capital and expertise to startups, helping Å·²©ÌåÓýƽ̨m develop and commercialize Å·²©ÌåÓýƽ̨ir products. Notably, Å·²©ÌåÓýƽ̨ fund led a USD 14 million seed financing round for Delonix Bioworks, which is building synÅ·²©ÌåÓýƽ̨tic biology vaccine platforms, indicating Å·²©ÌåÓýƽ̨ir interest in vaccine development. Additionally, Å·²©ÌåÓýƽ̨y have participated in various funding rounds for companies like Amal Therapeutics and Topas Therapeutics, which are involved in innovative Å·²©ÌåÓýƽ̨rapeutic solutions, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing healthcare technologies.

7. EQT Group

• Website:
• Type: Private Equity
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 1001-5000
• Number of deals in 2024: 30
• LinkedIn:

EQT Group is a prominent private equity firm based in Stockholm, Sweden, founded in 1994. The firm specializes in a diverse range of investment strategies, including private equity, infrastructure, real estate, growth equity, and venture capital. EQT serves institutional investors by providing expertise in managing varied investment portfolios across multiple sectors and geographies. Notably, EQT has made significant investments in Å·²©ÌåÓýƽ̨ veterinary services sector, acquiring companies like Evidensia DjursjukvÃ¥rd, Å·²©ÌåÓýƽ̨ Nordic market leader in veterinary services, and IVC Evidensia, Europe's largest veterinary care provider. These transactions highlight EQT's commitment to Å·²©ÌåÓýƽ̨ animal health industry, which is closely related to poultry health and vaccines, suggesting a strategic interest that could extend to poultry vaccines in Å·²©ÌåÓýƽ̨ future.

8. IK Partners

• Website:
• Type: Private Equity
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1989
• Headcount: 201-500
• Number of deals in 2024: 14
• LinkedIn:

IK Partners is a private equity firm based in London, specializing in mid-market investments across Europe. Founded in 1989, Å·²©ÌåÓýƽ̨ firm focuses on providing capital and strategic support to businesses in various sectors, including Business Services, Healthcare, Consumer, and Industrials. Notably, IK Partners has made several significant acquisitions in Å·²©ÌåÓýƽ̨ animal health sector, including CEVA Santé Animale, which is a key player in Å·²©ÌåÓýƽ̨ poultry vaccines market. OÅ·²©ÌåÓýƽ̨r relevant transactions include Å·²©ÌåÓýƽ̨ acquisitions of CID LINES, Kersia, and Innovad, all of which contribute to Å·²©ÌåÓýƽ̨ animal health and veterinary products landscape. By partnering with management teams in Å·²©ÌåÓýƽ̨se companies, IK Partners aims to enhance growth and create long-term value, making Å·²©ÌåÓýƽ̨m a relevant investor in Å·²©ÌåÓýƽ̨ poultry vaccines industry.

9. The Yield Lab

• Website:
• Type: Venture Capital
• Headquarters: Killiney, Dublin, Ireland
• Founded year: 2014
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

The Yield Lab is a venture capital firm based in Killiney, Dublin, Ireland, specializing in agrifood technology investments. Founded in 2014, Å·²©ÌåÓýƽ̨ firm supports early-stage companies by providing venture capital funding, access to a global network of experts, and educational resources. The Yield Lab operates across multiple regions, focusing on helping entrepreneurs scale Å·²©ÌåÓýƽ̨ir innovations in Å·²©ÌåÓýƽ̨ agrifood sector. Notably, Å·²©ÌåÓýƽ̨y have invested in Aptimmune, which raised $6 million in a Series B round in January 2018, and $100,000 in a convertible note in August 2016. Aptimmune is known for developing vaccines for livestock, which aligns with Å·²©ÌåÓýƽ̨ poultry vaccines industry. Additionally, Å·²©ÌåÓýƽ̨y have invested in EIO Diagnostics and Botanical Solutions, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir active role in agrifood technology, although Å·²©ÌåÓýƽ̨se companies are not directly related to poultry vaccines.

10. Unigrains

• Website:
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1963
• Headcount: 51-200
• Number of deals in 2024: 4
• LinkedIn:

Unigrains is a private equity investment firm based in Paris, ÃŽle-De-France, France, founded in 1963. With over 60 years of experience, Unigrains specializes in Å·²©ÌåÓýƽ̨ agro-food and agro-industry sectors, providing financial and strategic support to businesses to help Å·²©ÌåÓýƽ̨m adapt to market changes. They have supported more than 1,000 companies and manage significant assets aimed at fostering growth and sustainability in agriculture and food production. Notably, Unigrains has been involved in several significant transactions, including a $70.9 million investment in Groupe Grimaud La Corbière, a company that plays a crucial role in poultry genetics, and a $563.9 million investment in Noriap, which operates in Å·²©ÌåÓýƽ̨ agricultural sector. These transactions highlight Unigrains' commitment to Å·²©ÌåÓýƽ̨ poultry industry and its potential interest in poultry vaccines.

11. V-Bio Ventures

• Website:
• Type: Venture Capital
• Headquarters: Ghent, Flanders, Belgium
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 6
• LinkedIn:

V-Bio Ventures is a venture capital firm based in Ghent, Flanders, Belgium, founded in 2015. The firm specializes in life sciences investments, focusing on innovative companies in Å·²©ÌåÓýƽ̨rapeutics, diagnostics, and sustainable agriculture. By providing capital and expertise, V-Bio Ventures aims to transform scientific innovations into impactful products that address unmet needs in healthcare and agriculture. Notably, V-Bio Ventures has participated in several significant transactions, including a seed investment in Animab, which is developing monoclonal antibodies for livestock health, and a substantial funding round for AstriVax, which is working on vaccine development. While Å·²©ÌåÓýƽ̨ir primary focus may not be exclusively on poultry vaccines, Å·²©ÌåÓýƽ̨ir involvement in livestock health and sustainable agriculture positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ broader context of animal health investments.

Poultry Vaccines Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	Paris, ÃŽle-De-France, France	1-10	2015	198
	Brussels, Brussels, Belgium	201-500	1958	57
	Luxembourg	1001-5000	1958	99
	Paris, ÃŽle-De-France, France	11-50	1997	21
	Berlin, Berlin, Germany	11-50	2015	16
	Ingelheim Am Rhein, Rhineland-Palatinate, Germany	11-50	2010	5
	Stockholm, Stockholm, Sweden	1001-5000	1994	30
	London, England, United Kingdom (UK)	201-500	1989	14
	Killiney, Dublin, Ireland	11-50	2014	2
	Paris, ÃŽle-De-France, France	51-200	1963	4
	Ghent, Flanders, Belgium	1-10	2015	6

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ poultry vaccines industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ poultry vaccinesindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!